Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia
- Conditions
- HyperferritinemiaHypertriglyceridemia
- Interventions
- Behavioral: Dietary and lifestyle counseling.Procedure: Phlebotomy
- Registration Number
- NCT02526121
- Lead Sponsor
- Instituto Aragones de Ciencias de la Salud
- Brief Summary
The purpose of this study is to evaluate the effect of iron depletion with phlebotomies on blood triglyceride concentration, in subjects with hypertriglyceridemia and iron overload, compared with a dietary intervention alone.
All subjects in this study will follow dietary and lifestyle counseling in a period of 3 months.
A randomized group will receive phlebotomies every 3 weeks in this period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Hyperferritinemia: > 300µgr/L for male and >200µgr/L for female.
- Hypertriglyceridemia: > 200 mg/dL in two determinations after at least ten hours of fasting and lipid-lowering diet.
- Contraindications for phlebotomy: poor venous access, previous intolerance (hypotension or apprehension), heart disease, anemia.
- Subjects suffering from acute or chronic disease, including liver disease, diabetes, cancer, kidney disease or uncontrolled thyroid disease.
- Elevated C reactive protein (CRP) as a parameter of inflammation (>10mg/L).
- Alcohol intake: over 30 gr. per day for men and 25 gr. per day for women.
- Lipid lowering drugs use.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Dietary and lifestyle counseling. Dietary and lifestyle counseling. - Phlebotomy associated with dietary and lifestyle counseling Phlebotomy - Phlebotomy associated with dietary and lifestyle counseling Dietary and lifestyle counseling. -
- Primary Outcome Measures
Name Time Method Triglycerides concentration Three months before
- Secondary Outcome Measures
Name Time Method Iron parameters Three months before Ferritin level: \>300 µgr/L in men and \>200 µgr/L in women
Trial Locations
- Locations (1)
Hospital Universitario Miguel Servet
🇪🇸Zaragoza, Spain